1. Home
  2. Analysis
  3. Methyldopa
  4. Hydromorphone-hydrochloride

Methyldopa and Hydromorphone hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methyldopa (methyldopa) and Hydromorphone hydrochloride (hydromorphone hydrochloride). Common drug interactions include adiposis dolorosa among females.

The phase IV clinical study analyzes what interactions people have when they take Methyldopa and Hydromorphone hydrochloride. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Methyldopa?

Methyldopa has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 6,475 Methyldopa users. Check the latest studies of Methyldopa.

What is Hydromorphone hydrochloride?

Hydromorphone hydrochloride has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 13,898 Hydromorphone hydrochloride users. Check the latest studies of Hydromorphone hydrochloride.

On Jul, 07, 2026

12 people who take Methyldopa and Hydromorphone hydrochloride together, and have interactions are studied.

Methyldopa and Hydromorphone hydrochloride drug interactions.

What are the common drug interactions of Methyldopa and Hydromorphone Hydrochloride, by gender? *:

female:

  1. Adiposis dolorosa (multiple, painful lipomas)
  2. Apnoea (suspension of external breathing)
  3. Drug hypersensitivity
  4. Drug ineffective
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dyspnoea (difficult or laboured respiration)
  7. Enteritis (inflammation of the small intestine)
  8. Epistaxis (bleed from the nose)
  9. Fatigue (feeling of tiredness)
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

male:

n/a

What are the common drug interactions of Methyldopa and Hydromorphone Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Adiposis dolorosa (multiple, painful lipomas)
  2. Apnoea (suspension of external breathing)
  3. Drug hypersensitivity
  4. Drug ineffective
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dyspnoea (difficult or laboured respiration)
  7. Enteritis (inflammation of the small intestine)
  8. Epistaxis (bleed from the nose)
  9. Fatigue (feeling of tiredness)
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

60+:

n/a

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Methyldopa and Hydromorphone hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methyldopa and Hydromorphone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methyldopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydromorphone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methyldopa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydromorphone hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methyldopa and hydromorphone hydrochloride (the active ingredients of Methyldopa and Hydromorphone hydrochloride, respectively), and Methyldopa and Hydromorphone hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.